NIH-funded research R01 grant

Developing a new method to analyze cell signaling proteins

Official title: A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptors

Funded at Battelle Pacific Northwest Laboratories · NIH-11055999 · Data updated 2026-11-12

This study is looking at new ways to measure how certain proteins in our cells, called GPCRs, work and change, which could help us understand diseases better and improve treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBattelle Pacific Northwest Laboratories
NIH-funded
Lab location1 site (Richland, United States)
Project startJune 15, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$480,681
NIH project number5R01GM149650-03
Project IDNIH-11055999 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with inflammatory diseases that involve GPCRs, such as those affecting immune responses.

Less likely to help

Patients with conditions unrelated to GPCR signaling or those not experiencing inflammatory diseases may not benefit from this research.

What this research studies

This research focuses on improving mass spectrometry techniques to better understand how certain proteins, specifically G-protein coupled receptors (GPCRs), function in cellular signaling. By using advanced technology, the researchers aim to accurately measure how these proteins are modified through phosphorylation, which is crucial for their activity. This approach could lead to faster and more reliable results compared to traditional methods, ultimately enhancing our understanding of diseases linked to these proteins. Patients may benefit from insights gained about GPCRs, which are common drug targets.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for inflammatory diseases by providing deeper insights into GPCR function.

How similar studies have gone: Previous research has shown promise in using advanced mass spectrometry techniques for studying protein modifications, indicating potential success for this novel approach.

Where this research is happening

  • Battelle Pacific Northwest Laboratories
    Richland, United States
    Active

Researchers

  • Principal investigator: Jacobs, Jon — Battelle Pacific Northwest Laboratories
  • Study coordinator: Jacobs, Jon

Related research

Other NIH-funded projects on the same topics.

  • Proteomics Center for MoTrPAC to map exercise effects in human tissues

    A research center is studying how physical activity changes proteins and their modifications in muscles and fat to understand exercise benefits for chronic diseases.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11516019

  • Islet cell pathways and regulators in early type 1 diabetes

    Researchers will study how insulin-producing beta cells deteriorate before type 1 diabetes becomes clinically apparent, using cutting-edge tissue analysis to find molecular clues that could lead to new therapies.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11457916

  • Protein targets of nitazenes and their metabolites in human cells

    Researchers will map which human brain, heart, and lung proteins interact with nitazene opioids, helping explain why these drugs can be so potent and dangerous.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11440279

  • High-throughput multiomic profiling of single cells

    A new platform will measure proteins, RNAs, and metabolites in thousands of individual human cells to better understand how cells regulate themselves.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11428734

  • Single-cell phospho-proteomics to map breast tumor microenvironment

    A researcher will develop a new, highly sensitive single-cell proteomics tool to map proteins and phosphorylation in breast cancer tumor environments, helping doctors tailor treatments.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11394417

  • High-Throughput Lipid Profiling with Precise Structures for Phenotypic Screening

    A project to develop advanced lipid profiling that can precisely identify lipid structures to help understand and screen diseases like Alzheimer's.

    NIH research Battelle Pacific Northwest Laboratories · Richland, United States · NIH-11386439

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.